Trial
NCT01402817
Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Indiana University
Collaborators
United States Department of Defense; Pfizer
Condition
Neurofibromatosis
Intervention
Sutent®/Sunitinib
Why stopped
1 patient died of uncertain cause but possibly related to drug.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-03-14